EN বাং
Rabetac

Rabetac

Tablet (Enteric Coated)

🧬 Rabeprazole Sodium 🏭 Navana Pharmaceuticals Ltd.
GENERIC NAME
Rabeprazole Sodium
MANUFACTURER
Navana Pharmaceuticals Ltd.
UNIT PRICE
Unit Price: ৳ 6.90 (6 x 10: ৳ 414.00) Strip Price: ৳ 69.00
Indications
Pharmacology
Dosage & Administration
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Pediatric Usage
Storage Conditions

Indications

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Pharmacology

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Dosage & Administration

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Interaction

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Contraindications

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Side Effects

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Pregnancy & Lactation

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Precautions & Warnings

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Pediatric Usage

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Storage Conditions

Rabetac is indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

Alternative Medicines (Same Generic)

Acifix Capsule (Enteric Coated)

Beximco Pharmaceuticals Ltd.

Unit Price: ৳ 8.00 (6 x 10: ৳ 480.00) Strip Price: ৳ 80.00

Finix Tablet (Enteric Coated)

Opsonin Pharma Ltd.

Unit Price: ৳ 7.00 (7 x 20: ৳ 980.00) Strip Price: ৳ 140.00

Paricel Tablet (Enteric Coated)

ACI Limited

Unit Price: ৳ 3.51 (10 x 10: ৳ 351.00) Strip Price: ৳ 35.10

Paricel Tablet (Enteric Coated)

ACI Limited

Unit Price: ৳ 7.00 (10 x 10: ৳ 700.00) Strip Price: ৳ 70.00

Rabe Tablet (Enteric Coated)

Aristopharma Ltd.

Unit Price: ৳ 7.00 (7 x 20: ৳ 980.00) Strip Price: ৳ 140.00

Paricel Capsule (Enteric Coated)

ACI Limited

Unit Price: ৳ 8.00 (8 x 10: ৳ 640.00) Strip Price: ৳ 80.00

Rabeca Tablet (Enteric Coated)

Square Pharmaceuticals PLC

Unit Price: ৳ 7.00 (5 x 10: ৳ 350.00) Strip Price: ৳ 70.00

Rabecon Tablet (Enteric Coated)

Biopharma Limited

Unit Price: ৳ 6.00 (6 x 10: ৳ 360.00) Strip Price: ৳ 60.00

Rabeprol Tablet (Enteric Coated)

Somatec Pharmaceuticals Ltd.

Unit Price: ৳ 5.75 (6 x 10: ৳ 345.00) Strip Price: ৳ 57.50

Rabesec Tablet (Enteric Coated)

Drug International Ltd.

Unit Price: ৳ 6.00 (4 x 14: ৳ 336.00) Strip Price: ৳ 84.00